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Background
Clostridium difficile is the most common cause of antimi-
crobial-associated diarrhea and is a common healthcare
associated pathogen. While asymptomatic carriage
remains high among infants, recent epidemiological sur-
veillance has demonstrated a rise in the prevalence of
Clostridium difficile infection in children.
Methods
We present 4 cases of children admitted to the National
Institute for Infectious Diseases “Prof. Dr. Matei Balş” in
the last year with Clostridium difficile colitis; the children
had ages between 2 and 12 years. Diagnosis of infection
was based on the presence of three or more stools in a
24 hour period, isolation of the organism and detection
of toxins A/B in a diarrheal stool specimen (stool culture
and PCR assay). We studied the clinical aspects and evo-
lution after treatment.
Results
All children presented an important risk factor for Clostri-
dium difficile infection: antimicrobial therapy prior to
infection. Three children presented chronic pediatric
comorbidities: one case of Ewing’s sarcoma; one case of
gastroesophageal reflux disease, recent abdominal surgery
for gastric volvulus, use of proton pump inhibitors; one
case of milk protein allergy. The clinical signs and symp-
toms were: fever (3 cases), watery diarrhea (2 cases),
bloody diarrhea (2 cases), cramping abdominal pain,
vomiting, loss of appetite and malaise.
The children received antimicrobial therapy: oral metro-
nidazole in 2 cases, oral vancomycin in 2 cases, supportive
treatment and probiotics, with good outcome. All patients
recovered without complications. Relapse occurred in the
case with osteosarcoma, after cytostatic treatment and he
was treated with oral vancomycin. Rifaximin prophylaxis
associated to the next cytostatic treatment prevented
another relapse.
Conclusion
1. The diagnosis of Clostridium difficile colitis should be
suspected in patients with diarrhea and associated risk
factors, even in the pediatric population.
2. The increasing incidence of Clostridium difficile infec-
tion requires the implementation of appropriate policies
for antibiotic use and further studies investigating optimal
therapeutic and preventive strategies.
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